Wagner Paul A. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-08-15 5:15 pm Purchase |
2023-07-31 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 76,048 5.210% |
24,886![]() (+48.64%) |
Filing |
2021-09-16 4:05 pm Sale |
2021-09-07 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 51,162 9.100% |
-39,720![]() (-43.71%) |
Filing |
2020-06-25 4:16 pm Purchase |
2020-06-15 | 13D | Forte Biosciences, Inc. FBRX |
Wagner Paul A. | 90,882 21.040% |
90,882![]() (New Position) |
Filing |